272 related articles for article (PubMed ID: 28681696)
1. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
2. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
[TBL] [Abstract][Full Text] [Related]
3. MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.
Briggs MT; Condina MR; Ho YY; Everest-Dass AV; Mittal P; Kaur G; Oehler MK; Packer NH; Hoffmann P
Proteomics; 2019 Nov; 19(21-22):e1800482. PubMed ID: 31364262
[TBL] [Abstract][Full Text] [Related]
4. N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease.
Leijon H; Kaprio T; Heiskanen A; Satomaa T; Hiltunen JO; Miettinen MM; Arola J; Haglund C
J Clin Endocrinol Metab; 2017 Nov; 102(11):3990-4000. PubMed ID: 28938401
[TBL] [Abstract][Full Text] [Related]
5. Discovery of specific metastasis-related N-glycan alterations in epithelial ovarian cancer based on quantitative glycomics.
Zhang X; Wang Y; Qian Y; Wu X; Zhang Z; Liu X; Zhao R; Zhou L; Ruan Y; Xu J; Liu H; Ren S; Xu C; Gu J
PLoS One; 2014; 9(2):e87978. PubMed ID: 24516574
[TBL] [Abstract][Full Text] [Related]
6. Isomer-specific chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer.
Hua S; Williams CC; Dimapasoc LM; Ro GS; Ozcan S; Miyamoto S; Lebrilla CB; An HJ; Leiserowitz GS
J Chromatogr A; 2013 Mar; 1279():58-67. PubMed ID: 23380366
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
[TBL] [Abstract][Full Text] [Related]
8. Differential N-glycan patterns identified in lung adenocarcinoma by N-glycan profiling of formalin-fixed paraffin-embedded (FFPE) tissue sections.
Wang X; Deng Z; Huang C; Zhu T; Lou J; Wang L; Li Y
J Proteomics; 2018 Feb; 172():1-10. PubMed ID: 29157724
[TBL] [Abstract][Full Text] [Related]
9. Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma.
Anugraham M; Jacob F; Everest-Dass AV; Schoetzau A; Nixdorf S; Hacker NF; Fink D; Heinzelmann-Schwarz V; Packer NH
Mol Oncol; 2017 Nov; 11(11):1595-1615. PubMed ID: 28853212
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
[TBL] [Abstract][Full Text] [Related]
11. Mass Spectrometry Imaging of N-Glycans from Formalin-Fixed Paraffin-Embedded Tissue Sections Using a Novel Subatmospheric Pressure Ionization Source.
Shi Y; Li Z; Felder MA; Yu Q; Shi X; Peng Y; Cao Q; Wang B; Puglielli L; Patankar MS; Li L
Anal Chem; 2019 Oct; 91(20):12942-12947. PubMed ID: 31507162
[TBL] [Abstract][Full Text] [Related]
12. N-glycomic profiling as a tool to separate rectal adenomas from carcinomas.
Kaprio T; Satomaa T; Heiskanen A; Hokke CH; Deelder AM; Mustonen H; Hagström J; Carpen O; Saarinen J; Haglund C
Mol Cell Proteomics; 2015 Feb; 14(2):277-88. PubMed ID: 25452313
[TBL] [Abstract][Full Text] [Related]
13. The ascites N-glycome of epithelial ovarian cancer patients.
Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
[TBL] [Abstract][Full Text] [Related]
14. Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy.
Yang G; Tan Z; Lu W; Guo J; Yu H; Yu J; Sun C; Qi X; Li Z; Guan F
J Proteome Res; 2015 Feb; 14(2):639-53. PubMed ID: 25536294
[TBL] [Abstract][Full Text] [Related]
15. Alteration of N-glycans and expression of their related glycogenes in the epithelial-mesenchymal transition of HCV29 bladder epithelial cells.
Guo J; Li X; Tan Z; Lu W; Yang G; Guan F
Molecules; 2014 Dec; 19(12):20073-90. PubMed ID: 25470275
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
17. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.
Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH
Mol Cell Proteomics; 2014 Sep; 13(9):2213-32. PubMed ID: 24855066
[TBL] [Abstract][Full Text] [Related]
18. Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis.
Amin A; Bashir A; Zaki N; McCarthy D; Ahmed S; Lotfy M
World J Gastroenterol; 2015 May; 21(20):6167-79. PubMed ID: 26034352
[TBL] [Abstract][Full Text] [Related]
19. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS
Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680
[TBL] [Abstract][Full Text] [Related]
20. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]